Carbidopa-levodopa
Parkinson's disease, post-encephalitic parkinsonism, symptomatic parkinsonism
Indications
- Parkinson's disease
- post-encephalitic parkinsonism
- symptomatic parkinsonism
Adult dosing
- initial: dose: 1; unit: tablet; route: PO - SINEMET 25-100 tablet (carbidopa 25 mg / levodopa 100 mg); interval: SINEMET 25-100, three times a day; fixed: true; labelExcerpt: Dosage is best initiated with one tablet of SINEMET 25-100 three times a day.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Nonselective MAO inhibitors
- Known hypersensitivity
- Narrow-angle glaucoma
Clinical pearls
- Discontinue levodopa at least 12 hours before starting SINEMET.
- Monitor closely for involuntary movements and psychiatric symptoms.
- Evaluate vitamin B6 levels periodically during treatment.
- Patients may experience sudden onset of sleep without warning.
Source and review
- DailyMed label (carbidopa and levodopa, SINEMET), Set ID 9b17b028-964a-473c-823d-81423535bd66, effective 2026-08-01. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties